Browsing Tag
Taiwan biotech
4 posts
GlycoNex and Nippon Kayaku team up to advance next-generation ADC candidate GNX201-ADC in solid tumours
GlycoNex (4168) and Nippon Kayaku advance GNX201-ADC, a protease-activated ADC targeting solid tumours. Discover what this deal means for oncology. Read more.
EirGenix signs global licensing deal with Sandoz for second HER2 biosimilar EG1206A
EirGenix signs a USD 152M global deal with Sandoz for its Perjeta biosimilar EG1206A after FDA/EMA nod. Find out what this means for the HER2 drug race.
Can Mycenax’s ADC linker license deal with RIN boost Taiwan’s global CDMO standing?
Find out how Mycenax Biotech Inc. is reshaping Taiwan’s ADC CDMO positioning through a global linker technology license deal with Japan’s RIN Institute.
Taiwanese biotech firm Taicend Technology unveils five-part wound care portfolio at MEDICA 2025
Discover how Taicend Technology’s new wound-care products claim to halve healing time and expand their global footprint.